In Friday’s Wall Street session, BIMI International Medical Inc. (NASDAQ:BIMI) shares traded at $0.26, up 10.96% from the previous session.
1 analysts cover BIMI International Medical Inc. (NASDAQ:BIMI), according to research data. The consensus rating among analysts is ‘Hold’. As we calculate the median target price by taking the range between a high of $62.50 and a low of $62.50, we find $62.50. Given the previous closing price of $0.23, this indicates a potential upside of 27073.91 percent. BIMI stock price is now -18.43% away from the 50-day moving average and -66.33% away from the 200-day moving average. The market capitalization of the company currently stands at $8.51M.
The stock has received a hold rating from 1 analysts and a buy rating from 0. Brokers who have rated the stock have averaged $62.50 as their price target over the next twelve months.
A total of 36.90% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in BIMI stock. A new stake in BIMI International Medical Inc. shares was purchased by MILLENNIUM MANAGEMENT LLC during the first quarter worth $21,000. In total, there are 7 active investors with 0.80% ownership of the company’s stock.
On Friday morning BIMI International Medical Inc. (NASDAQ: BIMI) stock kicked off with the opening price of $0.2450. During the past 12 months, BIMI International Medical Inc. has had a low of $0.20 and a high of $5.90. As of last week, the company has a debt-to-equity ratio of 0.61, a current ratio of 1.10, and a quick ratio of 1.00. The fifty day moving average price for BIMI is $0.3094 and a two-hundred day moving average price translates $0.7502 for the stock.
The latest earnings results from BIMI International Medical Inc. (NASDAQ: BIMI) was released for Jun, 2022. The company reported revenue of $4.93 million for the quarter, compared to $9.26 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -46.78 percent.
BIMI International Medical Inc.(BIMI) Company Profile
BIMI International Medical Inc., together with its subsidiaries, engages in the retail and wholesale distribution of medical devices, and pharmaceutical and other healthcare products in the People’s Republic of China. The company operates in four segments: Wholesale Pharmaceuticals, Wholesale Medical Devices, Medical Services, and Retail Pharmacies. It distributes Stryker spinal products, Olympus endoscopes, imported imaging products, and diagnostic imaging equipment to drug stores, private clinics, pharmaceutical dealers, and hospitals in the Southwest region of the People’s Republic of China. The company also distributes generic drugs, Chinese herbal medicine, biochemical drugs, raw ingredients for pharmaceutical products, antibiotics, cardiovascular drugs, and anti-obesity medicines. In addition, it offers prescription and over-the-counter drugs, nutritional supplements, health foods, sundry products, traditional Chinese medicines, personal and family care products, medical devices, and miscellaneous items under the Lijiantang Pharmacy brand name. Further, the company provides medical services in the hospitals, as well as IT research and development services. It sells its medicine and other healthcare products to customers through its directly owned stores. The company was formerly known as BOQI International Medical Inc. and changed its name to BIMI International Medical Inc. in June 2021. BIMI International Medical Inc. was incorporated in 2000 and is based in Chongqing, the People’s Republic of China.